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Ethnopharmacological relevance: Cedrus atlantica essential oil (CaEO) presents analgesic and anti-in-
ﬂammatory sedative properties. However, it remains unknown whether CaEO alleviates acute post-
operative pain.
Materials and methods: Here, we investigated the effect of CaEO on postoperative pain and its me-
chanisms related to the descending pain control in Swiss males mice induced by a plantar incision
surgery (PIS) in the hindpaw.
Results: Inhalation of CaEO (5′, 30′ or 60′) markedly reduced mechanical hypersensitivity. This effect was
prevented by pre-treatment with naloxone or p-chlorophenylalanine methyl ester (PCPA, 100 mg/kg, i.
p.)-induced depletion of serotonin. In addition, p-alpha-methyl-para-tyrosin (AMPT, 100 mg/kg, i.p.)-
induced depletion of norepinephrine, intraperitoneal injection of the α2-adrenergic receptor antagonist
yohimbine (0.15 mg/kg, i.p.) or haloperidol (1 mg/kg, i.p.) an antagonist of dopaminergic (D1 and D2)
receptors prevented the effect of CaEO on hypersensitivity.
Conclusions: These ﬁndings suggest that CaEO alleviates postoperative pain by activating the descending
pain modulation pathways on the opioidergic, serotonergic, noradrenergic (α2-adrenergic) and dopa-
minergic (dopamine D1 and D2 receptors) systems.
& 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Pain is an important parameter in patient recovery and sa-
tisfaction after surgery. For many patients, pain due to surgical
incision can be severe despite treatment with conventional use of
opioids, non-steroidal anti-inﬂammatory drugs (NSAIDs) and local
anesthetics (Apfelbaum et al., 2003). Pain can be modulated by
several areas distributed throughout the neuraxis exert a top-
down modulation of pain sensation. This modulation is largely
mediated by descending monoaminergic pathways that either
inhibit or facilitate transmission of nociceptive information at therved.
n Health Sciences, University
, Brazil.
artins).level of the dorsal horn (Gebhart, 2004; Millan, 2002; Benarroch,
2008; Mason, 2005). Monoamines, including serotonin, nor-
epinephrine, and dopamine, act via different receptor subtypes to
exert a complex modulation of neurotransmitter release from
nociceptive afferents and excitability of dorsal horn neurons
(Millan, 2002; Benarroch, 2008).
Opioids play an important role in pain transmission both by
initiating the descending controls from the brainstem and by di-
rectly reducing the evoked activity of C and Aδ ﬁbers in the dorsal
horn via presynaptic opioid receptors. Thus, a signiﬁcant anti-
nociceptive effect mediated by opioid receptors in the nucleus
raphe magnus (NRM) through its descending pain-modulating
system has been reported recently in rats after repeated morphine
treatment (Ma et al., 2006).
Activations of descending pain modulation (noradrenergic,
serotonergic, dopaminergic and opioidergic pathways) by
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vior in persistent pain models (Obata et al., 2007; Pertovaara,
2006) or in postoperative pain model (Onttonen and Pertovaara,
2000), and these are effective targets for therapeutic strategy.
The use of integrative and complementary therapies as ad-
juncts to traditional Western medical practice has signiﬁcantly
increased in the United States over the past two decades. Ar-
omatherapy is the fastest growing integrative therapy (Buckle,
1997; Ehrlichman and Halpern, 1998; Buchbauer et al., 1993). Ar-
omatherapy includes the inhaled, absorbed, or ingested use of
essential oil extracts from plants and ﬂowers for prophylactic
medical care or active treatment (Buchbauer et al., 1993; Bouchra
et al., 2003).
Essential oils are volatile, natural, complex compounds char-
acterized by a strong odor and are formed by aromatic plants as
secondary metabolites. Essential oils obtained from different
species of Cedrus, such as C. atlantica, C. deodora and C. libani, have
been reported by their use in aromatherapy to obtain many clinical
beneﬁts traditionally ascribed to genitourinary, musculoskeletal
and cutaneous systems (Mojay, 2002, 2004; Sharma and Manhas,
2015; Lovell, 1998). Among important pharmacological properties
that support their clinical use, we can name the anti-inﬂammatory
and analgesic effects (Thabrew et al., 2003), as well as im-
munomodulatory (Shinde et al., 1999), antioxidant (Wu et al.,
2015), antibacterial (Zeng et al., 2012) and insecticidal (Lamiri
et al., 2001) activities. In terms of previous reports on the chemical
composition of this plant, the oil from the wood of this species has
been extensively studied, sesquiterpenoids of the himachalane
type being the major components (Plattier and Teisseire, 1974;
Teisseire and Plattier, 1974).
Regarding Cedrus atlantica ([Endl.] Manetti ex Carrière), also
known as Cedarwood, it is not known whether inhalation of its
essential oil (CaEO) alleviates pain behavior in a mouse model of
postoperative pain, and if so, how the descending inhibitory sys-
tems may be involved in this action. In the present study, we ex-
amined the effect of CaEO inhalation on pain behavior and its
mechanisms related to the descending opioid, serotonergic, nor-
adrenergic or dopaminergic systems in a mouse model of post-
operative pain, induced by a plantar incision surgery (PIS) in the
plantar aspect of the foot of mice.2. Materials and methods
2.1. Drugs
The following substances were used: Cedrus atlantica (Essential
Oil,) (Penny Price Aromatherapy, Hinckley, England, batch no:
CEDT1167); naloxone hydrochloride (a nonselective opioid re-
ceptor antagonist, experiment 3 (Tocris Cookson Inc., Ellisville,
MO, USA); morphine hydrochloride (a nonselective opioid re-
ceptor agonist, experiment 3 (Merck, Darmstadt, Germany);
p-chlorophenylalanine methyl ester (PCPA, inhibitor of the
synthesis of serotonin, experiment 4), alpha-methyl-para-tyrosin
(AMPT, an inhibitor of NE and dopamine synthesis), experiment 5)
clonidine hydrochloride (a selective α-2-adrenergic receptors
agonist, experiment 6), yohimbine hydrochloride (a selective α-2-
adrenergic receptors antagonist, experiment 6), haloperidol (an
antagonist of dopaminergic (D1 and D2), experiment 7, apomor-
phine (a dopamine D2 receptor agonist) experiment 7 (Sigma
Chemical Co, St Louis, Missouri).
Other substances were dissolved in saline. Drugs were deliv-
ered by intraperitoneal route, a constant volume of 10 ml/kg body
weight was injected. Appropriate control-treated groups also were
assessed simultaneously. The doses of all substances used were
chosen based on data in the literature (Martins et al., 2012, 2013)or were selected from preliminary experiments conducted in our
laboratory.
2.2. Analysis of volatile components of the Cedrus atlantica essential
oil
The oil was analyzed by gas chromatography (GC) to calculate
the retention indexes (IR) and by chromatography–mass spectro-
metry (GC–MS) to obtain their mass spectra. The GC analysis was
performed on SHIMADZU GC-14B equipped with and FID detector
and a LM-5 (30 mx0.25 mm0.3 mm) capillary column. Oven
temperature was programmed from 60 to 260 °C at 3 °C/min, and
ending with 10 min at 260 °C; temperature of the injector 250 °C
and detector 300 °C. Helium was used as carrier gas (1 ml/min)
and split ratio 1:40. The injection volume was 0.1 mL of the oils and
split ratio 1:40. The sample was dissolved in n-hexane. The GC/MS
analyses were conducted on Agilent Technologies 5975 Series MSD
(70 eV) instrument. A DB-5 column (30 m0.25 mm0.25 mm)
was used with helium as the carrier gas at a ﬂow of 1 mL/min. The
conditions of the program column temperature were: 60–290 °C
(3 °C/min) with isotherm at 290 °C to 5/min; injector temperature
260 °C, detector 280 °C. Sample volume injected was 1 ml. Split
1:10.
The components in the oil were identiﬁed by comparison of the
calculated retention indices (IR), mass spectra obtained by CG–MS
and literature data (Adams, 2007). The IR values of the compo-
nents were obtained by co-injection of mixture of n-alkanes series
(C5-C30) and using the equation reported by Van den Doll and
Kratz (1963). The concentration was calculated using the in-
dividual peak areas for each substance.
2.3. Animals
All animal care and experimental procedures were carried out
in accordance with the National Institutes of Health Animal Care
Guidelines (NIH publications number 80-23). All experiments
were approved by the Ethics Committee of the University of
Southern Santa Catarina at Palhoça, Santa Catarina, Brazil (protocol
number 12.014.4.06.IV) and were conducted using male Swiss
mice (25–35 g). The animals were housed at 2272 °C under a 12 h
light/12 h dark cycle (lights on at 6:00 a.m.) and with free access to
food and water. Mice were acclimated to the laboratory for at least
1 h before testing that was carried out between 8:00 and 12:00 h.
The number of animals and intensity of noxious stimuli used were
the minimum necessary to demonstrate the consistent effects of
treatments (Zimmermann, 1983). Control animals received the
same vehicle used to dilute the compounds.
2.4. Plantar incision surgery (PIS)
Here, we used a pre-clinical model of postoperative pain. Paw
incision in rodents induces a variety of nocifensive behaviors that
closely resemble the time course of postoperative pain in humans
(Brennan et al., 1983). The PIS was performed as previously de-
scribed (Martins et al., 2012, 2013; Pogatzki and Raja, 2003).
Brieﬂy, mice were anesthetized with 1–2% isoﬂurane delivered via
a nose cone. After sterile preparation of the right hind paw, a
5-mm longitudinal incision was made through skin and fascia of
the plantar surface using a number 11 scalpel blade. The incision
started 2 mm from the proximal edge of the heel and extended
toward the toes. After wound homeostasis, the skin was apposed
with an 8.0 nylon mattress suture, and the wound was covered
with 10% povidone-iodine solution. Control animals underwent a
sham procedure. That is, they were subjected to anesthesia but not
to PIS. Animals were allowed to recover in their cages, and sutures
were removed on the ﬁrst postoperative day.
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Inhalation of Cedrus atlantica essential oil (CaEO) was per-
formed as previously described by Barocelli et al. (2004). The vo-
lume of 200 ml of CAEO, contained in a 10 ml glass baker, were
positioned at the bottom of plastic cages (height 20 cm, width
30 cm, depth 20 cm) suddenly covered with plastic ﬁlm during
30 min in order to saturate the ambient. At saturation, the con-
centration of the oils in the cage was 2.4 ml/l. Mice introduced into
the cage were allowed to inhale oil vapors for controlled time
periods (1, 5, 30 and 60 min) prior to performing the ﬁnal ex-
periments. Control animals were caged in the same conditions but
in the absence of the tested oils (saline).
2.6. Evaluation of locomotor activity
Ambulatory behavior was assessed in an open-ﬁeld test as
previously described (Mazzardo-Martins et al., 2012). The appa-
ratus consisted of a wooden box measuring 4060x50 cm3. The
ﬂoor of the arena was divided into 12 identical squares. Mice in-
haled CaEO or saline for 30 min and the number of squares crossed
with all paws (crossings) was counted in a 6-min session, 30 min
beforehand inhalation.
2.7. Mechanical hypersensitivity
Mechanical hypersensitivity was measured as previously de-
scribed by Martins et al., (2013). The animals were acclimated in
individual clear boxes (97x11 cm3) on an elevated wire mesh
platform to allow access to the ventral surface of the hind paws.
The right hind paw was stimulated with a constant pressure of
0.4 g von Frey ﬁlaments (VFF) (Stoelting, Chicago, USA). The re-
sponse frequency to 10 applications was taken as the nociceptive
behavior. The results are expressed as the percentage of with-
drawal frequency. The day before surgery, the animals were sub-
jected for testing to characterize the baseline response. Only ani-
mals that showed a response rate around 20% were selected.
2.8. Experiment 1: effect of inhalation of Cedrus atlantica essential
oil on locomotor activity
In order to evaluate a possible non-speciﬁc muscle-relaxant or
sedative effect of the extract, mice were subjected to the open-
ﬁeld test. Mice were subjected to PIS inhaled Saline or CaEO for
0.5 h. Open-ﬁeld test was performed 0.5 h after inhalations.
2.9. Experiment 2: inhalation of Cedrus atlantica essential oil on
postoperative pain
To assess whether inhalation of CaEO alleviates pain behavior
in a mouse model of postoperative pain, mechanical hypersensi-
tivity was assessed before (baseline), 24 h after PIS and at 0.5, 1,
2 and 3 h after CaEO inhalation. In a separate series of experi-
ments, we evaluated mechanical hypersensitivity before (base-
line), 24 h after PIS and 0.5 h after CAEO inhalation at each day
after PIS, for 6 days. Furthermore, in order to verify the effect per se
of CaEO inhalation, naive animals inhaled the oil for 6 consecutive
days, being evaluated 0.5 h after the inhalation.
2.10. Participation of descending pain modulation pathways
2.10.1. Experiment 3: involvement of opioid system
To assess the participation of the opioid system in the anti-
hypersensitivity produced by CaEO inhalation, mice were sub-
jected to PIS. Mechanical hypersensitivity was tested 24 h after PIS.
Mice were pretreated with an intraperitoneal (i.p.) injection ofvehicle (10 ml/kg) or naloxone (1 mg/kg) (Martins et al., 2012).
After 20 min, animals inhaled Saline or CaEO for 0.5 h. Mechanical
hypersensitivity was evaluated using a von Frey monoﬁlament
(0.4 g) 0.5 h after inhalations.
Another group of mice was pretreated with vehicle (10 ml/kg, i.
p.) or naloxone (1 mg/kg, i.p.) and, after 20 mn, received sub-
cutaneous (s.c.) saline (10 ml/kg) or morphine (5 mg/kg) (Martins
et al., 2012). These groups were assessed 30 min after vehicle or
morphine treatment.
2.10.2. Experiment 4: involvement of serotoninergic system
To assess the possible contribution of descending serotonin
endogenous system on the antihypersensitivity produced by CaEO
inhalation, we examined the effects of depletion of central nor-
epinephrine using an inhibitor of serotonin synthesis (p-chlor-
ophenylalanine methyl ester, PCPA). The animals were pretreated
with an intraperitoneal injection of vehicle (10 ml/kg) or PCPA
(100 mg/kg) once a day, for 4 consecutive days, 3 days before and
24 h after PIS (Martins et al., 2013). Twenty minutes after the last
administration, animals inhaled vehicle or CaEO for 0.5 h. Me-
chanical hypersensitivity was evaluated using a von Frey mono-
ﬁlament (0.4 g) 0.5 h after inhalations.
Another group of mice was pretreated with vehicle (10 ml/kg, i.
p.) or PCPA (100 mg/kg, i.p.) and, after 20 min, received s.c. vehicle
(10 ml/kg) or morphine (5 mg/kg) (Martins et al., 2013). These
groups were assessed 0.5 h after vehicle or morphine treatments.
2.10.3. Experiment 5: involvement of noradrenergic system
To determine a possible involvement of the descending nora-
drenergic system in the on the antihypersensitivity produced by
CaEO inhalation, we examined the effects of depletion of central
norepinephrine using an inhibitor of the synthesis of nor-
epinephrine by inhibition of enzyme tyrosine hydroxylase, the
alpha-methyl-para-tyrosin (AMPT). The animals were pretreated
with an i.p. injection of vehicle (10 ml/kg) or AMPT (100 mg/kg)
(Cunha et al., 2013). Four hours after administration, animals in-
haled vehicle or CaEO for 0.5 h. Mechanical hypersensitivity was
evaluated using a von Frey monoﬁlament (0.4 g) 0.5 h after
inhalations.
Another group of mice was pretreated with vehicle (10 ml/kg, i.
p.) or AMPT (100 mg/kg, i.p.) and, after 20 min, received s.c. ve-
hicle (10 ml/kg) or morphine (5 mg/kg) (Cunha et al., 2013). These
groups were assessed 0.5 h after vehicle or morphine treatments.
2.10.3.1. Experiment 6: involvement of α2-adrenoceptors. In order to
further clarify the role of the noradrenergic system, we conducted
pharmacological experiments with adrenoceptor antagonists. Mice
were subjected to PIS and mechanical hypersensitivity was tested
24 h after PIS. Mice were pretreated with an i.p. injection of ve-
hicle (10 ml/kg) or yoimbine (0.15 mg/kg) (Martins et al., 2013).
After 20 min, animals inhaled vehicle or CaEO for 0.5 h. Mechan-
ical hypersensitivity was evaluated using a von Frey monoﬁlament
(0.4 g) 0.5 h after inhalations.
Another group of mice was pretreated with vehicle (10 ml/kg, i.
p.) or yoimbine (0.15 mg/kg, i.p.) and, after 20 min, received i.p.
vehicle (10 ml/kg) or clonidine (0.1 mg/kg) (Martins et al., 2013).
These groups were assessed 0.5 h after vehicle or clonidine
treatments.
2.10.4. Experiment 7: involvement of dopaminergic system
In order to verify the role of the dopaminergic system, we
conducted pharmacological experiments with haloperidol an an-
tagonist at dopaminergic (D1 and D2) receptors (Naidu et al.,
2003; Pandurangan et al., 2014). Mice were subjected to PIS and
mechanical hypersensitivity was tested 24 h after PIS. Mice were
pretreated with an i.p. injection of vehicle (10 ml/kg) or
Table 1
Chemical constitution of the Cedrus atlantica essential oil.
Components RTa (min) IRb Concentration (%)
Iso-longifolene (1) 18.826 1387 0.6
β-cubebene (2) 18.944 1390 0.6
α-cedrene (3) 19.109 1409 0.5
α-himachalene (4) 20.098 1447 16.6
γ-Gurjunene (5) 20.593 1470 0.5
γ-himachalene (6) 20.798 1480 10.4
ar-curcumene (7) 20.860 1483 2.3
β-himachalene (8) 21.442 1510 46.4
α-dehydro-ar-himachalene (9) 21.615 1518 1.2
δ-cadinene (10) 21.819 1527 2.3
γ-dehydro-ar-himachalene (11) 21.976 1532 1.4
α-calacorene (12) 22.298 1548 0.8
Oxido himachalene (13) 23.076 1582 0.6
β-himachalene oxide (14) 23.602 1605 0.2
α-acorenol (15) 24.227 1631 0.8
himachalol (16) 24.757 1648 0.7
bulnesol (17) 25.055 1660 0.9
Z-γ-atlantone (18) 25.660 1682 0.6
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2014). After 20 min, animals inhaled vehicle or CaEO for 0.5 h.
Mechanical hypersensitivity was evaluated using a von Frey
monoﬁlament (0.4 g) 0.5 h after inhalations.
Another group of mice was pretreated with vehicle (10 ml/kg, i.
p.) or apomorphine (1 mg/kg, i.p.) and, after 20 min, received i.p.
vehicle (10 ml/kg) or haloperidol (1 mg/kg) (Naidu et al., 2003;
Pandurangan et al., 2014). These groups were assessed 0.5 h after
vehicle or apomorphine treatments.
2.11. Statistical analysis
Results are presented as the mean7standard errors of the
mean for each group. Behavioral testing was analyzed using both
one-way analysis of variance (ANOVA) following Student–New-
man–Keuls test or two-way repeated measures ANOVA. A multi-
comparison post hoc test was performed using the Bonferroni's
test. Differences with a value of Po0.05 were considered
signiﬁcant.deodarone (19) 25.801 1687 1.5
E-γ-atlantone (20) 25.927 1692 0.9
Z-α-atlantone (21) 26.155 1701 0.4
Total 90.2
a RT, retention time.
b RI, retention index.3. Results
3.1. Analysis of volatile components of the CaEO
Through the comparison of the mass spectra obtained by CG–
MS, kovats indices (IR) ad literature data (Adams, 2007; Aberchane
et al., 2004; Derwich et al., 2010; Boudarene et al., 2004) was
possible identiﬁed some volatile constituents in the CaEO. The
results obtained with the analysis are demonstrated in Table 1 and
Fig. 1. In total were identiﬁed 21 constituents (90.2%), in which 12
are sesquiterpenes hydrocarbons (83.6%) and nine are oxygenated
sesquiterpenes (6.6%). The data obtained with the chemical ana-
lysis are in according with previous works reported in literature
(Aberchane et al., 2004; Derwich et al., 2010; Boudarene et al.,
2004).
Of the compounds analyzed, the sesquiterpenes hydrocarbons
α-himachalene (16.6%), γ-himachalene (10.4%) and β-himachalene
(46.4%) are the majority compounds, in which the component β-
himachalene is the most abundant and represent practically the
half of percentage of the oil composition.
3.2. Spontaneous locomotor activity
The CaEO did not affect the locomotor activity in the open-ﬁeld
test when compared with animals that inhaled vehicle (saline).
The means7SEM of crossed squares were 126.8720.0,
114.7723.5 and 107.6715.4 for the naïveþvehicle, PISþvehicle
and PISþCaEO (data not shown).
3.3. Inhalation of Cedrus atlantica essential oil alleviates post-
operative pain
The results presented in Fig. 2 (panel A) show that acute in-
halation of CaEO for different times decreased mechanical hy-
persensitivity induced by PIS. Signiﬁcant differences between
groups (PISþvehicle vs PISþCaEO 30′ or 60′) were observed at 0.5,
(Po0.05), 1 (Po0.05), and 2 h (Po0.05) after inhalations. Fur-
thermore, CaEO 5′ decreased mechanical hypersensitivity 0.5 h
after inhalation. However, CaEO 1′ had no effect on the response
frequency and was not signiﬁcantly different from the PISþvehicle
group (Fig. 2, panel A). In addition, the daily treatment of animals
with CaEO 30′ decreased the mechanical hypersensitivity induced
by PIS when evaluated 0.5 h after treatment. This effect was evi-
dent until the ﬁfth day of treatment (Fig. 2, panel B). In naïve mice
the daily treatment of animals with vehicle 30′ or CaEO 30′ had noeffect on the response frequency and was not signiﬁcantly differ-
ent between groups were observed until the sixth day of treat-
ments (Fig. 2, panel C).
3.4. Involvement of the opioid system
Since CAEO 30′ showed a signiﬁcant effect on mechanical hy-
persensitivity for up to 2 h (Fig. 3, panel A), we focused on the 30′
time point, a period of inhalation (treatment) at which CaEO had
no signiﬁcant effect locomotor activity. Administration of naloxone
(opioid antagonists) by themselves did not alter paw mechanical
hypersensitivity (Fig. 3, panel A and B). Systemic administration of
naloxone, 20 min before mobilization of the CaEO 30′, prevented
the decreased in the mechanical hypersensitivity resulting from
the inhalation (Fig. 3, panel A). Percentage of response frequency
values for the group pre-treated with naloxone via i.p. route was
signiﬁcantly higher when compared to vehicle plus CaEO group,
30 min after inhalations (Fig. 3 panel A).
The results depicted in Fig. 3 panel B, in experiment positive
control, the pretreatment of mice with naloxone given 20 min
before, prevented the antihypersensitivity caused by morphine
compared with group control (vehicleþmorphine).
3.5. Involvement of the serotoninergic system
Fig. 4 panel A shows that the pre-treatment of mice with PCPA
was able to prevent the reduction of mechanical hypersensitivity
elicited by inhalation of CaEO 30′. PCPA without CaEO 30′ had no
effect on the increased response frequency being similar to i.p.
injection of vehicle without CaEO 30′. The results presented in
Fig. 4 panel B show that the pretreatment of mice with PCPA,
prevented the reduction of mechanical hypersensitivity caused by
morphine (used as a positive control).
3.6. Involvement of the noradrenergic system
Fig. 5 panel A shows that the pre-treatment of mice with AMPT
was able to prevent the reduction of mechanical hypersensitivity
caused by inhalation of CaEO 30′. AMPT without CaEO 30′ had no
effect on the increased response frequency being similar to i.p.
Fig. 1. Chemical proﬁle of Cedrus atlantica essential oil.
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Fig. 5 panel B show that the pretreatment of mice with AMPT,
prevented the reduction of mechanical hypersensitivity caused by
morphine (used as a positive control).
We also determined the role of α2-adrenoceptors on the anti-
hypersensitivity effect of CaEO 30′ in the postoperative pain
model. We administered a selective α2 antagonist (yohimbine)
systemically (Fig. 5, panel C). The pretreatment with yohimbine
had no effect on response frequency, and the thresholds were si-
milar to those of i.p. injections of vehicle without CaEO 30′ (Fig. 5,
panel C and D). In addition, the response frequency values for the
groups pretreated with yohimbine were signiﬁcantly higherFig. 2. Effect of CaEO inhalation on mechanical hypersensitivity after plantar incision su
hours after surgery (panel A). In operated animals, the daily treatment of animals with 3
vehicle or CaEO 30-min (panel C). Each point represents the mean of 8 animals and ver
when compared with basal (B) condition or *Po0.05, when compared with control alocompared with those of the vehicleþCaEO 30′ group, 0.5 h after
inhalation (Fig. 5, panel C and D). Furthermore, the results pre-
sented in Fig. 5 show panel D that the pretreatment of mice with
yohimbine, prevented the reduction of mechanical hypersensitiv-
ity caused by clonidine (used as a positive control).
3.7. Involvement of the dopaminergic system
Fig. 6 panel A shows that the pre-treatment of mice with ha-
loperidol prevented the reduction of mechanical hypersensitivity
induced by inhalation of CaEO 30′. The results presented in Fig. 6
panel B show that the pretreatment of mice with haloperidol, alsorgery in the paw of mice. Acute CaEO inhalation in 1, 5, 30 or 60- min twenty-four
0-min CaEO inhalation (panel, B). In naïve mice the daily treatment of animals with
tical lines show the SEM. The symbols denote a signiﬁcant difference of #Po0.05,
ne group. CaEO: Cedrus atlantica essential oil; B: baseline analysis.
Fig. 3. Involvement of the opioid system in antihypersensitivity effect caused by CaEO inhalation. Intraperitoneal (i.p.) pre-treatment with naloxone (1 mg/kg, i.p., panel A-B)
on the antihypersensitivity effect of CaEO inhalation (panel A) or morphine (5 mg/kg, s.c., panel B). Each point represents the mean of 8 animals and vertical lines show the
SEM. The symbols denote a signiﬁcant difference of *Po0.05 when compared with VehicleþVehicle inhalation (control) group; #Po0.05 when compared with Vehi-
cleþCaEO inhalation, alone group. CaEO: Cedrus atlantica essential oil.
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apomorphine (used as a positive control). Haloperidol without
CaEO 30′ had no effect on the increased response frequency being
similar to i.p. injection of vehicle without CaEO 30′.4. Discussion
Aromatherapy involves the therapeutic use of essential oils
extracted from various parts of aromatic plants with the intent to
calm, balance, and rejuvenate mind, body, and spirit (Robins,
1999). It is currently used in the management of depression,
stress-related disorders, anxiety, some cognitive disorders, in-
somnia and pain (Perry and Perry, 2006). Beneﬁcial effects on pain
of inhaled essential oils in animals and in humans have been re-
ported (Barocelli et al. 2004; Salamati et al., 2014; Nagata et al.,
2014). The genus Cedrus, is native to the Atlas Mountains of Algeria
and Morocco, is a tree up to 40 m high, with broad level branches.
Essential oils have been widely used in traditional medicine. In
relation to Cedrus atlantica, among others, anti-inﬂammatory and
analgesic effects have been registered (Thabrew et al., 2003).
However, analgesic effect on postoperative pain, as well as the
possible mechanisms implicated on this, has not been investigated
yet. Thus, the present study demonstrated the efﬁcacy and safety
of inhalation of CaEO on postoperative pain.
This study showed for the ﬁrst time that the inhalation of CaEO
displayed antihypersensitivity effect on postoperative pain evoked
by plantar incision surgery (PIS) in mice. The inhalation of CaEO
did not alter spontaneous locomotor activity in the time that
caused signiﬁcant antihypersensitivity effect. Furthermore, hereFig. 4. Involvement of the serotoninergic system in antihypersensitivity effect caused b
panel A and B) on the antihypersensitivity effect of CaEO inhalation (panel A) or morphi
lines show the SEM. The symbols denote a signiﬁcant difference of *Po0.05 when com
with VehicleþCaEO inhalation, alone group. CaEO: Cedrus atlantica essential oil.we demonstrated that inhalation of CaEO reduces pain behavior
through activation of descending pain modulation pathways. To
our knowledge this is the ﬁrst report of this kind in the literature.
Phytochemical analysis of the CaEO reveled that sesquiterpenes
hydrocarbons α-himachalene (16.6%), γ-himachalene (10.4%) and
β-himachalene (46.4%) are the majority compounds, in which the
component β-himachalene is the most abundant and represent
practically the half of percentage of the oil composition. These
data are in agree with reported by Aberchane and co-authors
(2004) which described the chemical composition of CaEO and
identiﬁed α-himachalene (7.4–16.4%), γ-himachalene (5.1–8.6%),
β-himachalene (23.4–40.4%) and (E)-α-atlantone (5.2–29.5%) as
the majority compounds.
In the present study, we attempted to characterize some of the
mechanisms through which the inhalation of CaEO exerts its an-
tihypersensitivity effect in a mouse model of postoperative pain.
Previous studies have shown that the activation of the descending
inhibition pathway results in analgesia after surgery. Descending
control arises from a number of supraspinal sites, including the
midline periaqueductal gray-rostral ventromedial medulla (PAG-
RVM) system, and the more lateral and caudal dorsal reticular
nucleus (DRt) and ventrolateral medulla (VLM) for inhibition of
pain sensation includes projections from various brainstem nuclei
to the spinal cord dorsal horn via the dorsolateral funiculus (DLF).
More speciﬁcally, DLF ﬁbers are comprised of serotonergic pro-
jections from the raphe nuclei, dopaminergic projections from the
ventral tegmental area (VTA), and noradrenergic projections from
the locus coeruleus (LC). These descending ﬁbers suppress pain
transmission at the nociceptive spinal cord neurons presumably by
hyperpolarizing afferent sensory neurons using endogenousy CaEO inhalation. Intraperitoneal (i.p.) pre-treatment with PCPA (100 mg/kg, i.p.,
ne (5 mg/kg, s.c., panel B). Each point represents the mean of 8 animals and vertical
pared with VehicleþVehicle inhalation (control) group; #Po0.05 when compared
Fig. 5. Involvement of the noradrenergic system in antihypersensitivity effect caused by CaEO inhalation. Intraperitoneal (i.p.) pre-treatment with AMPT (100 mg/kg, i.p.,
panel A and B) on the antihypersensitivity effect of CaEO inhalation (panel A) or morphine (5 mg/kg, s.c., panel B). The pre-treatment with yohimbine (0.15 mg/kg, i.p., panel
C and D) on the antihypersensitivity effect of CaEO inhalation (panel C) or clonidine (0.1 mg/kg, i.p., panel D). Each point represents the mean of 8 animals and vertical lines
show the SEM. The symbols denote a signiﬁcant difference of *Po0.05 when compared with VehicleþVehicle inhalation (control) group; #Po0.05 when compared with
VehicleþCaEO inhalation, alone group. CaEO: Cedrus atlantica essential oil.
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mediators (Millan, 2002; Marks et al., 2009).
The results reported here indicate, to our knowledge for the
ﬁrst time, that pretreatment of animals with naloxone, a non-
selective opioid receptor antagonist, at a dose that produced no
signiﬁcant effect on postoperative pain, completely prevented the
antihypersensitivity effect of inhalation of CaEO. The opioid system
plays a very important role in the control of pain. Opioid receptors
are widely expressed in the central and peripheral nervous sys-
tems and in numerous nonneuronal tissues (Iwaszkiewicz et al.,
2013). There are several areas of the CNS that, directly or indirectly,
are activated by nociceptive inputs, are targets of opioids, and
participate in the central modulation of pain (Basbaum and Fields,
1984). Therefore, we suggest that inhalation of CaEO could releases
endogenous opioids like encephalin, endorphin or others that are
responsible for antihypersensitivity effect.Fig. 6. Involvement of the dopaminergic system in antihypersensitivity effect caused by
panel A and B) on the antihypersensitivity effect of CaEO inhalation (panel A) or apom
vertical lines show the SEM. The symbols denote a signiﬁcant difference of *Po0.05 w
compared with VehicleþCaEO inhalation, alone group. CaEO: Cedrus atlantica essentialThe present study also showed that the monoaminergic system
probably also is involved in the antihypersensitivity effect of CaEO
inhalation. This conclusion is derived from the fact that 1) deple-
tion of endogenous serotonin with the tryptophan hydroxylase
inhibitor PCPA, at a dose known to decrease the cortical content of
serotonin and to signiﬁcantly prevent the morphine anti-
hypersensitivity, largely antagonized the antihypersensitivity ac-
tion of CaEO inhalation; 2) depletion of endogenous nor-
epinephrine (NE) and dopamine with an inhibitor of NE and do-
pamine synthesis AMPT, at a dose known to decrease the cortical
content of NE and dopamine and to signiﬁcantly prevent the
morphine antihypersensitivity, largely antagonized the anti-
hypersensitivity action of CaEO inhalation; 3) selective or non-
selective antagonists of α2 or D1 and D2 receptors, namely yo-
himbine and haloperidol, respectively, consistently prevented the
antihypersensitivity caused by inhalation of CaEO when analyzedCaEO inhalation. Intraperitoneal (i.p.) pre-treatment with haloperidol (1 mg/kg, i.p.,
orphine (1 mg/kg, i.p., panel B). Each point represents the mean of 8 animals and
hen compared with VehicleþVehicle inhalation (control) group; #Po0.05 when
oil.
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whether intratecal administration of the antagonists should pre-
vented the antihypersensitivity caused by inhalation of CaEO, as a
manner to better clarify the participation of these neuro-
transmitters released in the spinal cord to the the studied phe-
nomena. This should be considered in future studies.
Essential oil components might be absorbed into the circula-
tory system, reach the CNS, and act on receptors of neuro-
transmitters to induce the effects (Kagawa et al., 2003). However,
in inhalation aromatherapy, aroma component molecules are
dissolved in the mucus on the olfactory mucosa and stimulate
olfactory cells, and then the aroma information is converted to
electric signals and transmitted to the olfactory nerve and olfac-
tory bulb (OB) (Amir et al., 1999). Notably, it has been reported that
exposure to essential oil increases Fos expression in the olfactory
system (main olfactory bulb, anterior olfactory nucleus and piri-
form cortex) and the limbic system (amygdala, infralimbic cortex
and entorhinal cortex) in rats. Neural circuit processing of odor
information in the OB is regulated by afferent axons from olfactory
receptor neurons (Amir et al., 1999).
In summary, the present results provide convincing evidence
that CaEO inhalation exerts a rapid onset, relatively long-lasting
and pronounced systemic antihypersensitivity against pain beha-
vior in a mouse model of postoperative pain at a inhalation time
that does not interfere with the locomotor activity. In view of
these results, we can speculate that the CaEO inhalation may elicit
an antihypersensitivity effect either by releasing endogenous
opioid, serotonin, NE and/or dopamine that can bind to their
speciﬁc their receptors, or by interacting with their receptors.
However, other studies are necessary to further substantiate this
assertion. Thus, our data support the hypothesis that inhalation of
CaEO reduces behavior pain through activation opioidergic, ser-
otonergic, noradrenergic and dopaminergic systems.Conﬂict of interests
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Aromatherapy: includes the inhaled, absorbed, or ingested use of essential oil
extracts from plants and ﬂowers for prophylactic medical care or active
treatment;
Essential oils: are substance volatile, natural, complex compounds characterized
by a strong odor and are formed by aromatic plants as secondary metabolites;
Plantar incision surgery: is a pre-clinical (animal) model of postoperative pain.
